한국동물생명공학회지 (Journal of Animal Reproduction and Biotechnology)

  • 제36권2호
  • /
  • Pages.116-120
  • /
  • 2021
  • /
  • 2671-4639(pISSN)
  • /
  • 2671-4663(eISSN)
한국동물생명공학회 (The Korean Society of Animal Reproduction and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Case reports of amniotic membrane derived-cell treatment for feline chronic renal failure

  • 투고 : 2021.05.13
  • 심사 : 2021.06.15
  • 발행 : 2021.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Three different cats who had chronic kidney disease (CKD) were treated for more than one month with fluid therapy in an animal clinic. Although this long-term treatment and hospitalization, there was no clinical improvement in clinical signs as well as serum biochemical indexes including blood urea nitrogen (BUN), creatinine (CREA), and phosphate (PHOS). All cases were then injected three times with allogeneic stem cells through an intravenous route for treatment on Day 0, 7, and 14 or 30. On the same day, clinical observation and blood tests for serum biochemistry were conducted together. Upon administrating stem cells to the CKD cats, clinical conditions and the indexes of BUN and CREA were clinically improved within normal ranges. Additionally, one of the cats who had the renal cysts presented clinical improvement with showing decreased cysts size than before.

키워드

과제정보

This work has supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019M3A9H1103582).

참고문헌

  1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. 2004. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8:R204-R212. https://doi.org/10.1186/cc2872
  2. Cetinkaya B, Unek G, Kipmen-Korgun D, Koksoy S, Korgun ET. 2019. Effects of human placental amnion derived mesenchymal stem cells on proliferation and apoptosis mechanisms in chronic kidney disease in the rat. Int. J. Stem Cells 12:151-161. https://doi.org/10.15283/ijsc18067
  3. Chan KW, Ping TY, Chou SJ, Zheng ZJ, Yang WC, Lai JM, Lo DY, Chang CC, Wu JT. 2014. Case report: treatment of an elderly dog with concurrent heart disease and acute uremia by hemodialysis. Taiwan Vet. J. 40:95-100. https://doi.org/10.1142/S1682648514500127
  4. Chung BH. 2019. Use of mesenchymal stem cells for chronic kidney disease. Kidney Res. Clin. Pract. 38:131-134. https://doi.org/10.23876/j.krcp.19.051
  5. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. 2007. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25:100-106. https://doi.org/10.1038/nbt1274
  6. Filioli Uranio M, Valentini L, Lange-Consiglio A, Caira M, Guaricci AC, L'Abbate A, Catacchio CR, Ventura M, Cremonesi F, Dell'Aquila ME. 2011. Isolation, proliferation, cytogenetic, and molecular characterization and in vitro differentiation potency of canine stem cells from foetal adnexa: a comparative study of amniotic fluid, amnion, and umbilical cord matrix. Mol. Reprod. Dev. 78:361-373. https://doi.org/10.1002/mrd.21311
  7. Finco DR, Brown SA, Brown CA, Crowell WA, Cooper TA, Barsanti JA. 1999. Progression of chronic renal disease in the dog. J. Vet. Intern. Med. 13:516-528. https://doi.org/10.1111/j.1939-1676.1999.tb02204.x
  8. Jo JH, Kim KH, Kim TM. 2019. The potential of renal progenitor cells in kidney diseases: preclinical findings. J. Anim. Reprod. Biotechnol. 34:70-74. https://doi.org/10.12750/JARB.34.2.70
  9. Lee HJ, Jeon RH, Park BJ, Jang SJ, Lee SL, Rho GJ, Kim SJ, Lee WJ. 2019a. Differentiation inductions altered telomere length and telomerase activity in human dental pulpderived mesenchymal stem cell. J. Anim. Reprod. Biotechnol. 34:93-99. https://doi.org/10.12750/JARB.34.2.93
  10. Lee HJ, Park BJ, Jeon RH, Jang SJ, Son YB, Lee SL, Rho GJ, Kim SJ, Lee WJ. 2019b. Alteration of apoptosis during differentiation in human dental pulp-derived mesenchymal stem cell. J Anim. Reprod. Biotechnol. 34:2-9. https://doi.org/10.12750/JARB.34.1.2
  11. Mahiddine FY, Qamar AY, Kim MJ. 2020. Canine amniotic membrane derived mesenchymal stem cells exosomes addition in canine sperm freezing medium. J Anim. Reprod. Biotechnol. 35:268-272. https://doi.org/10.12750/JARB.35.3.268
  12. Moon SW, Lee HJ, Lee WJ, Ock SA, Lee SL. 2018. Trans-differentiation induction of human-mesenchymal stem cells derived from different tissue origin and evaluation of their potential for differentiation into corneal epithelial-like cells. J. Emb. Trans. 33:85-97. https://doi.org/10.12750/JET.2018.33.2.85
  13. Peired AJ, Sisti A, Romagnani P. 2016. Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int. 2016:4798639.
  14. Polzin DJ. 2017. Chronic kidney disease. In: Ettinger SJ, Feldman EC, Cote E (Eds.), Textbook of Veterinary Internal Medicine. 8th ed, Elsevier, St. Louis, pp. 1938-1958.
  15. Quimby JM, Webb TL, Gibbons DS, Dow SW. 2011. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J. Feline Med. Surg. 13:418-426. https://doi.org/10.1016/j.jfms.2011.01.005
  16. Quimby JM, Webb TL, Habenicht LM, Dow SW. 2013. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res. Ther. 4:48. https://doi.org/10.1186/scrt198
  17. Vidane AS, Souza AF, Sampaio RV, Bressan FF, Pieri NC, Martins DS, Meirelles FV, Miglino MA, Ambrosio CE. 2014. Cat amniotic membrane multipotent cells are nontumorigenic and are safe for use in cell transplantation. Stem Cells Cloning 7:71-78.
  18. Webb TL, Quimby JM, Dow SW. 2012. In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. J. Feline Med. Surg. 14:165-168. https://doi.org/10.1177/1098612X11429224